🇺🇸 FDA
Patent

US 9913885

Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

granted A61KA61K2039/53A61K2039/884

Quick answer

US patent 9913885 (Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same) held by Inovio Pharmaceuticals, Inc. expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K2039/53, A61K2039/884, A61K39/00, A61K39/0011